Fig. 2From: Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched studySurvival of patients in the AC group, the MAC group and the ACMC (1–50%) group after matching. A. All involved patients. B. TNM stage I patients. C. TNM stage II patients. D. TNM stage III patients. E. ROC curve for determining the cut-off value of MC proportion for prognostic predictionBack to article page